Feedstuffs is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Kemin expands global vaccine partnership

NicoElNino/iStock/Thinkstock financial business money concept
New partnership with ME VAC creates opportunities for Kemin to enter global vaccine market for multiple animal species.

Kemin Industries announced an expansion of its partnership with ME VAC, an animal vaccine manufacturer based in Cairo, Egypt, to further grow Kemin's portfolio in the global animal vaccination market.

"We believe in the importance of providing healthy and efficient solutions for animals. With a focus on transforming lives and creating a sustainable future, we know that non-antibiotic alternatives are increasingly important to our customers," Kemin president and chief executive officer Dr. Chris Nelson said. "Growing our partnership with ME VAC will enhance our ability to have a larger presence in the animal vaccine marketplace and create more innovations by expanding collaborations for R&D [research and development] projects."

Kemin became a small investor in ME VAC several years ago. The new agreement increases Kemin's investment and participation with ME VAC, providing Kemin with an opportunity to distribute vaccines globally outside the Arabic-speaking countries in the Middle East, the announcement said.

"We are very excited to have Kemin as a trusted partner. This investment will significantly improve our capability to expand globally and drive innovation at a more rapid pace," ME VAC chairman and CEO Dr. Magdy ElSayed said.

Kemin said it continues to invest in non-antibiotic solutions in the animal health market to support the growing demand to minimize the use of antibiotics in food-producing animals. With this investment, Kemin will now have access to a modern vaccine plant with production and R&D capabilities to support future growth.

"As the feed and animal production industries continue to evolve, customers are searching more aggressively for innovation that adds real value," said GS Ramesh, global group president, Kemin Animal Nutrition & Health. "Kemin continues to be the key driver of global product and technology innovation. This new partnership will further strengthen our capability to quickly scale up new innovation while maintaining our quality and safety standards for global regulatory requirements."

Kemin Industries is a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80% of the world with its products and services. The company supplies more than 500 specialty ingredients for human and animal health and nutrition, pet food, aquaculture, nutraceutical, food technologies, crop technologies and textile industries.

For more than half a century, Kemin has been dedicated to using applied science to address industry challenges and offer product solutions to customers in more than 120 countries. Kemin provides ingredients to feed a growing population with its commitment to the quality, safety and efficacy of food, feed and health-related products.

Established in 1961, Kemin is a privately held, family-owned and -operated company with more than 2,800 global employees and operations in 90 countries, including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, San Marino, Singapore, South Africa and the U.S.

Source: Kemin Industries, which is solely responsible for the information provided and is wholly owned by the source. Informa Business Media and all its subsidiaries are not responsible for any of the content contained in this information asset.
TAGS: Business
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.